<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02619188</url>
  </required_header>
  <id_info>
    <org_study_id>2015/894</org_study_id>
    <nct_id>NCT02619188</nct_id>
  </id_info>
  <brief_title>Nutritional Markers in Normal and Hyperemesis Pregnancies</brief_title>
  <acronym>PUQE-M</acronym>
  <official_title>Pregnancy Unique Questionnaire of Emesis (PUQE) Methode Evaluation; Relation Between Rate of Nausea/Vomiting in Pregnancy (PUQE-score), Self-reported Nutritional Intake and Biochemical Nutritional Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the rate of nausea and nutritional status in patients with hyperemesis
      gravidarum (severe nausea and vomiting in pregnancy) and healthy pregnant women using a
      questionnaire (PUQE-score), self-reported food/drink intake form and blood test. The
      Investigators aim for developing normal range of prealbumin measurements (reference values)
      during first trimester of pregnancy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women affected with hyperemesis gravidarum are at severe nutritional risk. Reference values
      for biochemical parameters evaluating nutritional status during early pregnancy needs to be
      determined.

      The investigators will compare clinical nutritional parameters (weight gain/weight loss) with
      rate of nausea (PUQE-questionnaire), self-reported nutritional intake form and biochemical
      measurements (prealbumin) in women admitted to hospital with hyperemesis gravidarum and
      healthy pregnant women.

      For hyperemesis patients measurements will be repeated at discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prealbumin in normal pregnancy</measure>
    <time_frame>Within 24h at inclusion</time_frame>
    <description>Serum Prealbumin measured during first trimester of pregnancy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prealbumin related to nutritional parameters</measure>
    <time_frame>Within 24h at inclusion</time_frame>
    <description>Prealbumin level correlated to PUQE-score and weight change in normal and hyperemesis pregnancies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Prealbumin</measure>
    <time_frame>Patients will be followed until discharge from hospital, a mean of 5 days, and blood sampling repeated at discharge</time_frame>
    <description>Change in Serum Prealbumin during hospital treatment of hyperemesis gravidarum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prealbumin in Hyperemesis gravidarum</measure>
    <time_frame>Within 2h from admission to hospital</time_frame>
    <description>Serum Prealbumin measured when admission to hospital</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hyperemesis Gravidarum</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
    <description>Hyperemesis gravidarum patients admitted to hospital PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis), Intervention at discharge : PUQE-form, Nutritional form and Blood sampling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control: Healthy pregnant women</arm_group_label>
    <description>Outpatients NOT subjected to severe nausea and emesis (PUQE-score &lt;13). PUQE-form inclusion (PUQE-score), Nutritional form inclusion, Blood sampling inclusion (Prealbumin analysis).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PUQE-form inclusion</intervention_name>
    <description>PUQE-form encompassing last 24 hours completion</description>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
    <arm_group_label>Control: Healthy pregnant women</arm_group_label>
    <other_name>Pregnancy Unique Questionnare of Emesis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional form inclusion</intervention_name>
    <description>Food-list form encompassing last 24 hours completion</description>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
    <arm_group_label>Control: Healthy pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling inclusion</intervention_name>
    <description>Measurement of biochemical nutrition marker(s); Prealbumin</description>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
    <arm_group_label>Control: Healthy pregnant women</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intervention at discharge</intervention_name>
    <description>PUQE-form, nutritional form and Blood sampling</description>
    <arm_group_label>Hyperemesis gravidarum</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Women admitted to hospital due to Hyperemesis gravidarum

          -  Healthy pregnant women (without hyperemesis gravidarum)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women &lt; 16 weeks of gestation

          -  Admitted to hospital for hyperemesis gravidarum (HG group) with nausea and vomiting in
             pregnancy with at least two of following criteria; weight loss, dehydration,
             fluid-/electrolyte disturbances, ketonuria

        Exclusion Criteria:

          -  Non-viable pregnancy diagnosed at time of inclusion

          -  Unable to understand Norwegian

          -  PUQE-score &gt;= 13 (control group)

          -  Nausea an vomiting in pregnancy caused by other conditions than Hyperemesis gravidarum
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jone Trovik, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior consultant</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jone Trovik, MD, PhD</last_name>
    <phone>0047 55974200</phone>
    <phone_ext>4256</phone_ext>
    <email>jone.trovik@helse-bergen.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <state>Hordaland</state>
        <zip>5021</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jone Trovik, MD, PhD</last_name>
      <phone>55974200</phone>
      <phone_ext>4256</phone_ext>
      <email>jone.trovik@helse-bergen.no</email>
    </contact>
    <investigator>
      <last_name>Jone Trovik, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Birkeland E, Stokke G, Tangvik RJ, Torkildsen EA, Boateng J, Wollen AL, Albrechtsen S, Flaatten H, Trovik J. Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study. PLoS One. 2015 Apr 1;10(4):e0119962. doi: 10.1371/journal.pone.0119962. eCollection 2015.</citation>
    <PMID>25830549</PMID>
  </reference>
  <reference>
    <citation>Stokke G, Gjelsvik BL, Flaatten KT, Birkeland E, Flaatten H, Trovik J. Hyperemesis gravidarum, nutritional treatment by nasogastric tube feeding: a 10-year retrospective cohort study. Acta Obstet Gynecol Scand. 2015 Apr;94(4):359-67. doi: 10.1111/aogs.12578. Epub 2015 Feb 17.</citation>
    <PMID>25581215</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2015</study_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nutrition</keyword>
  <keyword>Hyperemesis gravidarum</keyword>
  <keyword>Prealbumin</keyword>
  <keyword>Questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperemesis Gravidarum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

